Mots-clés » Conferences

Kubernetes 101 Workshop

Today I TA’d (Teacher’s Assistant) a course with Bridget at GOTO Chicago Conference. There were a number of workshops besides just the Kubernetes 101 like; … 245 mots de plus

Unknown Code Ramblings

ASIL 2018 Recap: Building Victim-Led Coalitions in the Pursuit of Accountability

By Amy Flick

One of the first programs in ASIL’s 2018 Annual Meeting was a look at how victim-led prosecution efforts after mass human rights events can be more effective than those brought by states. 855 mots de plus

Conferences

Call for Papers - AGLSP 2018 Fall Conference

The Association of Graduate Liberal Studies Programs (AGLSP), a professional organization that provides working adults with interdisciplinary graduate-level education in the liberal arts and sciences, is calling for papers for the… 36 mots de plus

Conferences

ASIL 2018 Recap: International Law as a Tool in the Fight Against IUU Fishing and Seafood Slavery

By Jessica Pierucci

The Friday, April 6, 2018 ASIL Annual Meeting panel International Law as a Tool in the Fight against IUU Fishing and Seafood Slavery… 1 009 mots de plus

Conferences

Foucault's Confessions of the Flesh - talk at Goldsmiths, 9 May 2018

I’ll be talking about Foucault’s Les aveux de la chair at Goldsmiths University on May 9th at 3pm at the Centre for Philosophy and Critical Thought. 190 mots de plus

ASIL 2018 Recap: New Technologies in International Criminal and Human Rights Investigations and Fact-Finding

By Susan Gualtier

On Thursday, April 5th, I attended a panel entitled “New Technologies in International Criminal and Human Rights Investigations and Fact-Finding.”  The panel explored the increasing use of new technologies, such as social media, satellite data, mobile phone apps, and drone technology, in human rights fact-finding, particularly where sites are inaccessible or pose an especially high risk to human rights investigators. 652 mots de plus

Conferences

Replicor discloses long term functional control of HBV and HDV infection in high proportions of treated patients at EASL 2018

Below, we are re-publishing with permission the press-release issued by Replicor on the 13th of April 2018

MONTREAL, April 13, 2018 – Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B virus (HBV) and chronic HBV and hepatitis delta virus (HDV) co-infection, presented today the evolving long-term follow-up data from its REP 301-LTF and REP 401 studies at the 2018 International Liver Conference of the European Association for the Study of the Liver (EASL) held April 11-15, 2018 in Paris, France. 362 mots de plus

Clinical Accelerator